IRIS
CANDIDO, SAVERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.240
EU - Europa 1.768
AS - Asia 1.421
SA - Sud America 310
AF - Africa 175
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.919
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.131
IT - Italia 742
SG - Singapore 666
CN - Cina 508
IE - Irlanda 383
BR - Brasile 290
UA - Ucraina 197
DE - Germania 149
CI - Costa d'Avorio 108
CA - Canada 93
RU - Federazione Russa 80
VN - Vietnam 63
IN - India 40
KR - Corea 37
FI - Finlandia 36
SN - Senegal 36
GB - Regno Unito 30
SE - Svezia 29
FR - Francia 23
NL - Olanda 21
BD - Bangladesh 19
CH - Svizzera 17
TR - Turchia 16
AT - Austria 14
ZA - Sudafrica 14
IQ - Iraq 11
MX - Messico 11
UZ - Uzbekistan 10
PL - Polonia 9
IR - Iran 8
NG - Nigeria 8
AR - Argentina 7
ES - Italia 7
PK - Pakistan 7
VE - Venezuela 6
GR - Grecia 5
HK - Hong Kong 5
BE - Belgio 4
BG - Bulgaria 4
KZ - Kazakistan 4
NP - Nepal 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
JP - Giappone 3
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
TN - Tunisia 3
BY - Bielorussia 2
CL - Cile 2
CZ - Repubblica Ceca 2
IL - Israele 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
KI - Kiribati 1
LI - Liechtenstein 1
LT - Lituania 1
MA - Marocco 1
NI - Nicaragua 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 6.919
Salva come PNG Salva come JPEG
Città #
Santa Clara 655
Chandler 420
Singapore 405
Dublin 375
Jacksonville 278
Chicago 216
Catania 209
Boardman 151
Abidjan 108
Cambridge 100
Lawrence 100
Andover 91
Hefei 85
Grafing 84
Nanjing 82
Beijing 81
Toronto 71
Ashburn 68
Houston 56
Des Moines 55
Wilmington 52
Los Angeles 49
Dong Ket 47
Civitanova Marche 43
Palermo 37
Seoul 37
Dakar 36
Columbus 30
Council Bluffs 30
San Mateo 30
The Dalles 28
Hebei 27
São Paulo 26
Nanchang 25
Helsinki 23
Rome 22
Saint Petersburg 22
Shenyang 19
Jiaxing 16
Falls Church 14
Acireale 13
Bremen 13
Guangzhou 13
Hanoi 13
Naples 13
New York 13
Dallas 12
Dearborn 12
Messina 12
Padova 12
Rio de Janeiro 12
Ottawa 11
Belo Horizonte 10
Munich 10
Augusta 9
Milan 9
Nuremberg 9
Redwood City 9
Tianjin 9
Abuja 8
Aci Catena 8
Jinan 8
Johannesburg 8
Mascalucia 8
Norwalk 8
Changsha 7
Florence 7
Kochi 7
Lappeenranta 7
Leawood 7
Mumbai 7
San Francisco 7
Baghdad 6
Boston 6
Brooklyn 6
Den Haag 6
Frankfurt Am Main 6
Redmond 6
Turku 6
Amsterdam 5
Ankara 5
Ardabil 5
Cape Town 5
Genoa 5
Hong Kong 5
London 5
Maletto 5
Misterbianco 5
Ningbo 5
Seattle 5
Tashkent 5
Vasto 5
Vienna 5
Warsaw 5
Bari 4
Brussels 4
Campinas 4
Chennai 4
Edinburgh 4
Guarulhos 4
Totale 4.755
Salva come PNG Salva come JPEG
Nome #
Gut Microbiota and Cancer: From Pathogenesis to Therapy 201
Computational modelling in melanoma for novel drug discovery 100
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 98
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma 96
Prognostic significance of deregulated microRNAs in uveal melanomas 96
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 93
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 93
Analysis of the RAC1 mutations in cutaneous melanoma patients with occupational sun exposure 93
Droplet digital pcr analysis of liquid biopsy samples unveils the diagnostic role of hsa-mir-133a-3p and hsa-mir-375-3p in oral cancer 93
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease 90
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 89
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells 89
Cutaneous melanoma: From pathogenesis to therapy 86
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 84
Abstract 5305: DNA methylation and gene expression in melanoma: A large-scale integrated analysis 84
Environment and bladder cancer: Molecular analysis by interaction networks 84
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 84
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 83
Advances in targeting signal transduction pathways. 83
Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer 83
Nitric Oxide in Hematological Cancers: Partner or Rival? 83
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? 83
microRNAs and thyroid cancer: Biological and clinical significance (Review). 82
MMP-9 as a marker-of response to treatment with B-Raf inhibitors in cutaneous melanoma 82
Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development 81
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 80
Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots 78
Emerging targeted therapies for melanoma treatment (review) 77
Analysis of the B-RafV600E mutation in cutaneous melanoma patients with occupational sun exposure 76
Pericytes in microvessels: From “mural” function to brain and retina regeneration 75
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 73
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 72
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain 70
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 70
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 70
Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment 70
Overactivation of IL6 cis‑signaling in leukocytes is an inflammatory hallmark of deep vein thrombosis 69
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance 68
A Tailored Health Surveillance Program Unveils a Case of MALT Lymphoma in a HCV-positive Health-Care Worker 68
Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells 66
Patient-derived tumor organoids for drug repositioning in cancer care: A promising approach in the era of tailored treatment 65
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 64
Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells 64
Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey 64
MMP-9 as a candidate marker of response to BRAF inhibitors in melanoma patients with BRAFV600Emutation detected in circulating-free DNA 64
BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review) 64
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 64
Cutaneous melanoma and the immunotherapy revolution (Review) 64
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals. 61
Diagnostic and Prognostic Significance of a Four-miRNA Signature in Colorectal Cancer 60
Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma 60
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression 59
Role of microRNAs as novel diagnostic biomarkers and potential therapeutic targets for hearing disorders (Review) 58
Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis 58
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells 58
Role of the transcription factor Yin Yang 1 and its selectively identified target survivin in high-grade b-cells non-Hodgkin lymphomas: Potential diagnostic and therapeutic targets 58
Analisi delle mutazioni Rac1 nei lavoratori con melanoma cutaneo esposti al sole per motivi professionali 57
Dysregulation of IL-6 cis- and trans-signaling and high frequency of IL6R rs2228145(C>A) in the management of Deep Vein Thrombosis 56
Targeting signaling pathways involved in metastasis in cancer stem cells 56
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 56
Analysis of PIK3CA mutations in cutaneous melanoma patients with occupational sun exposure 55
Low levels of inflammation and the absence of subclinical atherosclerosis in rheumatoid arthritis 54
Suppressing prostate cancer by targeting NGAL 53
Functions of NGAL and GSK-3beta in sensitivity to targeted, chemo- and hormonal-based therapies 53
Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study 53
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals 53
The tumor microenvironment in hepatocellular carcinoma 52
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 52
Interaction between matrix metalloproteinase-9 (MMP-9) and neutrophil gelatinase-associated lipocalin (NGAL): A recent evolutionary event in primates 52
YY1 silencing induces 5-fluorouracil-resistance and BCL2L15 downregulation in colorectal cancer cells: Diagnostic and prognostic relevance 51
Overexpression of Sthamin-1 in lung cancer from patients exposed to asbestos: an "in silico" evaluation 49
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells 49
Cancer therapy and treatments during COVID-19 era 49
Novel insights into epigenetic regulation of il6 pathway: In silico perspective on inflammation and cancer relationship 49
Role of Oral Microbiota Dysbiosis in the Development and Progression of Oral Lichen Planus 49
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 48
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases. 48
Implication of IL-6 in the development of HCV-associated non-Hodgkin lymphoma 48
Low Glycemic Index Diet, Exercise and Vitamin D to Reduce Breast Cancer Recurrence: Rationale for the Design of a Clinical Trial 47
V600E B-Raf mutation is associated with chemoresistance in ovarian cancer 47
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma 46
Detection of B-Rat mutations in ovarian cancer is associated with chemoresistance 46
Metformin influences drug sensitivity in pancreatic cancer cells 46
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression 46
Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity. 46
The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways 46
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 45
Overexpression of Sthamin-1 is associated with the development of lung cancer developed in patients exposed to asbestos 45
Interactions between immune and environmental stimuli in non-Hodgkin Lymphoma 45
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals 45
Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma 44
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity 43
MMP-9 is a candidate marker of response to treatment with dabrafenib in melanoma cells 43
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder 43
MMP-9 is down-regulated after treatment with Vemurafenib in A375 and A2058 melanoma cells 43
Transcription analysis of Neutral Associated Lipocalin (NGAL) in Hepatocellular Carcinoma 43
Overexpression of nectin like-5 is associated with a malignant phenotype in cutaneous melanoma 43
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy 42
IL-6-174 G > C and MMP-9-1562 C > T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients. 42
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines 42
Totale 6.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.137
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021615 0 31 62 4 107 33 75 0 109 15 121 58
2021/2022727 62 107 5 33 102 15 100 25 52 23 21 182
2022/20231.326 114 69 30 144 118 201 11 208 321 25 56 29
2023/2024540 20 80 32 27 24 100 25 34 11 20 93 74
2024/20252.652 24 390 143 142 589 286 131 103 210 266 176 192
2025/2026494 328 166 0 0 0 0 0 0 0 0 0 0
Totale 7.110